Compare LTRN & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LTRN | ABLV |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6M | 44.9M |
| IPO Year | 2020 | 2022 |
| Metric | LTRN | ABLV |
|---|---|---|
| Price | $1.71 | $0.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 143.7K | 25.1K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $0.54 |
| 52 Week High | $4.70 | $1.30 |
| Indicator | LTRN | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 21.29 | 50.22 |
| Support Level | $1.11 | $0.63 |
| Resistance Level | $3.01 | $1.22 |
| Average True Range (ATR) | 0.17 | 0.11 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 5.80 | 22.87 |
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.